Conventional medical therapies have not been very successful in treating adults with refractory septic shock. The effects of direct hemoperfusion using polymyxin B and veno-arterial extracorporeal membrane oxygenation (ECMO) for refractory septic shock remain uncertain. A 66-year-old man was admitted to the emergency department and suffered from sepsis-induced hemodynamic collapse. For hemodynamic improvement, we performed direct hemoperfusion using polymyxin B. Computed tomography scan of this patient revealed emphysematous pyelonephritis (EPN), for which he underwent emergent nephrectomy with veno-arterial ECMO support. To the best of our knowledge, this is the first report of successful treatment of EPN with refractory septic shock using polymyxin B hemoperfusion and nephrectomy under the support of ECMO.
The proximal right internal carotid artery was almost totally occluded as it underwent severe stenosis.
The patient was treated with ECMO for three more days.
ECMO support was successfully discontinued on the sixth day of his stay in the hospital. Thereafter, he was on ventilator support for one more week because of mentality. Fourteen days after the operation, he was transferred to the general ward and his mental state improved enough to decipher instructions. And the follow-up echocardiography showed normal left ventricular systolic function. He was discharged on the 32 nd day of his hospital stay. The brief course of the patient is shown in Fig. 2 .
Discussion
The patient experienced EPN and refractory septic shock.
Septic shock of intra-abdominal origin is usually caused by the hemodynamics. [6] This result supports that PMX-DHP therapy may be effective in patients, after controlling the infection source. However, in our case, the patient developed uncontrolled infection, and this is why his condition deteriorated even after being subjected to PMX-DHP therapy.
Severe cardiac dysfunction is reportedly observed in 17% of cases diagnosed with septic multiple organ dysfunction syndrome. [7] ECMO is expected to be effective in neonates and children who develop septic cardiomyopathy. These children undergo cardiogenic refractory shock despite being treated with conventional modes of treatment. In this situation, the ECMO could provide extra time for recovery of the failing heart and support the perfusion of major organs until cardiac function spontaneously recovers and infection control can be achieved using antibiotics or interventions.
However, the efficacy of mechanical circulatory assistance remains controversial in adults with refractory septic shock.
The chances of survival and hospital discharge was 71%
(10/14) in a study conducted by Brechot et al. [3] but only 15% (8/52) in a study conducted by Huang et al. [4] According to a recently released report of our hospital, the chances of survival and hospital discharge was 22% (7/32) despite providing such patients with ECMO support. [5] Recent studies [4, 5] 
